2025-02-27  9:16:51 AM Chg. -0.2000 Volume Bid9:59:57 PM Ask9:59:57 PM Market Capitalization Dividend Y. P/E Ratio
85.3000EUR -0.23% 200
Turnover: 17,160
87.0000Bid Size: 200 87.2000Ask Size: 200 221.07 bill.EUR - -

Business description

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through its prescription medicines, vaccines, biologic therapies and animal health products, the company works with customers and operate in more than 140 countries to deliver innovative health solutions. Merck also demonstrates its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
 

Management board & Supervisory board

CEO
Robert M. Davis
Management board
Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Chirfi Guindo, Betty Larson, Dean Y. Li, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary
Supervisory board
Robert M. Davis, Douglas M. Baker, Jr., Mary Ellen Coe, Pamela J. Craig, Thomas H. Glocer, Surendralal L. Karsanbhai, Risa J. Lavizzo-Mourey, Stephen L. Mayo, Paul B. Rothman, Patricia F. Russo, Christine E. Seidman, Inge G. Thulin, Kathy J. Warden
 

Company data

Name: Merck & Co. Inc.
Address: 126 East Lincoln Avenue,Rahway, NJ 07065 USA
Phone: +1-908-740-4000
Fax: -
E-mail: -
Internet: www.merck.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: 83.84%
IPO date: -

Investor relations

Name: -
IR phone: +1-732-594-1468
IR Fax: -
IR e-mail: investor_relations@merck.com

Main Shareholders

Others
 
64.78%
Vanguard Group Inc
 
9.66%
Blackrock Inc.
 
7.97%
State Street Corp
 
4.61%
Wellington Management Group Llp
 
3.38%
Geode Capital Management, Llc
 
2.19%
Fmr Llc
 
1.69%
Morgan Stanley
 
1.58%
Bank Of America Corp /De/
 
1.50%
Others
 
2.64%